check_circleStudy Completed

Bayer Identifier:
92001
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study to evaluate endometrial safety of a transdermally administered Estradiol / Levonorgestrel preparation in hormone therapy in postmenopausal women

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
219
Trial Dates
April 2000 - August 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Climara PRO (E2/LNG)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Leicester, LE1 5WW, United Kingdom
Completed
Manchester, M15 6SX, United Kingdom
Completed
Birmingham, B15 2SQ, United Kingdom
Completed
Waterloo, L22 0LG, United Kingdom

Primary Outcome

Secondary Outcome

Trial design

An open-label, multi-center study to describe endometrial safety of a transdermally administered estradiol / levonorgestrel preparation in hormone therapy over 24 months (26 cycles) in postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.